ilShinbiobase Co. Ltd
ilShinbiobase Co. Ltd operates in Diversified Metals & Mining.
ilShinbiobase Co. Ltd (068330) - Total Assets
Latest total assets as of June 2024: ₩60.89 Billion KRW
Based on the latest financial reports, ilShinbiobase Co. Ltd (068330) holds total assets worth ₩60.89 Billion KRW as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ilShinbiobase Co. Ltd - Total Assets Trend (2016–2023)
This chart illustrates how ilShinbiobase Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
ilShinbiobase Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2023)
ilShinbiobase Co. Ltd's total assets of ₩60.89 Billion consist of 76.8% current assets and 23.2% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 5.2% |
| Accounts Receivable | ₩2.22 Billion | 3.7% |
| Inventory | ₩10.32 Billion | 17.0% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩1.75 Billion | 2.9% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how ilShinbiobase Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ilShinbiobase Co. Ltd's current assets represent 76.8% of total assets in 2023, an increase from 57.8% in 2016.
- Cash Position: Cash and equivalents constituted 5.2% of total assets in 2023, down from 10.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 3.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 17.0% of total assets.
ilShinbiobase Co. Ltd Competitors by Total Assets
Key competitors of ilShinbiobase Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
464680
KQ:464680
|
Korea | ₩31.23 Billion |
ilShinbiobase Co. Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - ilShinbiobase Co. Ltd generates 0.27x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, ilShinbiobase Co. Ltd generates $ 10.28 in net profit.
ilShinbiobase Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 18.10 | 8.78 | 4.19 |
| Quick Ratio | 18.10 | 6.80 | 3.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩44.00 Billion | ₩ 37.88 Billion | ₩ 20.77 Billion |
ilShinbiobase Co. Ltd - Advanced Valuation Insights
This section examines the relationship between ilShinbiobase Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.7% |
| Total Assets | ₩60.62 Billion |
| Market Capitalization | $10.00K USD |
Valuation Analysis
Below Book Valuation: The market values ilShinbiobase Co. Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: ilShinbiobase Co. Ltd's assets grew by 3.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for ilShinbiobase Co. Ltd (2016–2023)
The table below shows the annual total assets of ilShinbiobase Co. Ltd from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | ₩60.62 Billion | +3.71% |
| 2022-12-31 | ₩58.45 Billion | +3.57% |
| 2021-12-31 | ₩56.44 Billion | +13.91% |
| 2020-12-31 | ₩49.55 Billion | +8.60% |
| 2019-12-31 | ₩45.63 Billion | +15.42% |
| 2018-12-31 | ₩39.53 Billion | +2.70% |
| 2017-12-31 | ₩38.49 Billion | +2.21% |
| 2016-12-31 | ₩37.66 Billion | -- |